Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085580 (
essential hypertension
)
14,686
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Abnormalities in Ca metabolism in genetic hypertension have been suggested by studies of the spontaneously hypertensive rat and of humans with
essential hypertension
. A state of relative Ca deficiency in genetic hypertension was previously hypothesized to explain the reduced serum ionized Ca, increased serum
parathyroid hormone
levels, and the association between oral Ca loading and mild reduction in blood pressure. Renal Ca leak, reduced intestinal Ca absorption, and diminished Ca intake were further postulated to account for the Ca deficient state. This hypothesis, however, is not supported by the following lines of evidence in genetic hypertension: the absence of fasting hypercalciuria owing to intrinsic tubular defects, increased net Ca absorption in vivo despite greater Ca retention before and during established hypertension, increased intracellular free Ca concentrations, the failure to aggravate the hypertension by 50% reduction in dietary Ca intake, and the failure to ameliorate the hypertension by maneuvers that augment Ca balance (parenteral Ca administration, a high Mg diet, and 1,25-dihydroxyvitamin D3 injections). The available literature may be explained by the alternative hypothesis that genetic hypertension is characterized by generalized membrane defects in Ca regulation, resulting in a relative increase in cytosolic free Ca. The mechanism (or mechanisms) and physiological consequences of the disturbances in Ca homeostasis, however, remain to be defined.
...
PMID:The nature and role of disturbances in calcium metabolism in genetic hypertension. 353 40
The effect of calcium supplementation on blood pressure was studied in three groups: eight normotensive subjects, 14 borderline essential hypertensive subjects, and 11 established essential hypertensive subjects (EEH). All subjects were outpatients and were given 6 g of calcium lactate (779 mg of elemental calcium) daily for 16 weeks. In EEH, systolic blood pressure was decreased significantly by 6 mmHg, but diastolic blood pressure was not decreased significantly (2 mmHg). In other groups, blood pressure was not reduced significantly. In all groups, urinary excretion of calcium was increased significantly but urinary excretion of other electrolytes, such as sodium, potassium and phosphate did not change. Serum electrolytes, various hormones, such as
parathyroid hormone
, 1-25(OH)2D3, 25OHD3, plasma renin activity, plasma aldosterone, plasma norepinephrine and epinephrine, and cardiac output did not change throughout this study. There were no adverse effects observed during this trial. From these results, it was concluded that daily administration of 6 g of calcium lactate produces a slight antihypertensive effect in EEH, and that this might be useful as a supplementary treatment for
essential hypertension
, especially in the aged.
...
PMID:Effect of calcium supplementation on blood pressure in essential hypertensive subjects. 362 59
Relations between indices of mineral metabolism and blood pressure were examined in 182 subjects, comprising 58 patients with
essential hypertension
(
EHT
) and 124 healthy subjects attending a general health survey. Multivariate techniques of statistical analysis were employed to test the hypothesis of different relationships between blood pressure and calcium metabolism within the subpopulations and to eliminate confounding effects of age, sex and obesity. Plasma ionized calcium was inversely related and the urinary calcium excretion positively related to blood pressure in the total group. This was not significantly different between the groups. Serum
parathyroid hormone
(
PTH
) was, however, related to diastolic blood pressure only in the
EHT
group. The
EHT
patients had significantly lower plasma levels of ionized calcium, significantly higher levels of
PTH
and significantly greater excretion of calcium in the urine than the healthy subjects. The results of this investigation support the hypothesis that among patients with
EHT
the renal tubular reabsorption of calcium is impaired resulting in a reduction of plasma ionized calcium and thereby stimulation of
PTH
. The findings of linear relationships suggests the possibility of a direct association between calcium metabolism and the regulation of blood pressure.
...
PMID:Relationships between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. 366 47
Calcium metabolism has been investigated in patients with
essential hypertension
and normal renal function to evaluate the renal calcium handling and the reported increase in renal calcium loss. In 55 hypertensive and 55 sex- and age-matched healthy normotensive subjects creatinine clearance, serum total and ionized calcium, plasma
parathyroid hormone
and 24 h urinary excretion of calcium, sodium and cAMP were measured. In a subgroup of 20 hypertensive patients and 20 controls the fasting calcium excretion rate was also measured. Both 24 h and fasting calcium excretion rates were higher in the hypertensive group; so also were plasma
parathyroid hormone
and urinary cAMP. Serum total and ionized calcium levels were not different in the two groups. After intravenous calcium infusion (15 mg 3 h-1 kg-1) in seven hypertensive patients and controls, the hypertensive patients excreted more calcium at all serum calcium concentrations. These results support the hypothesis of primary renal calcium leak in
essential hypertension
. Enhanced urinary calcium excretion rate may cause compensatory parathyroid overactivity.
...
PMID:Abnormalities of calcium metabolism in essential hypertension. 630 48
Calcium metabolism in otherwise uncomplicated term pregnancies associated with
essential hypertension
is characterized by significantly reduced levels of
parathyroid hormone
and ionized calcium, as well as significantly increased levels of phosphorus in both the mother and fetus. It is not possible at this time to delineate with certainty the precise pathophysiology of these changes.
...
PMID:Calcium metabolism in the hypertensive mother, fetus, and newborn infant. 665 May 97
Disorders of calcium metabolism are not generally considered important either clinically or pathophysiologically in
essential hypertension
. Recent reports, though, suggest that increased parathyroid gland function may be one of the more common endocrine disturbances associated with hypertension. We measured serum
parathyroid hormone
(
PTH
) concentrations as well as routine blood and urine chemistries in 34 hypertensives. Their mean
PTH
, 79.1 +/- 3.1 muliter Eq/muliter, was significantly higher (p less than 0.025) than the mean
PTH
, 66.9 +/- 3.3, of an age- and sex-matched normotensive control population. The mean serum calcium, 9.5 +/- 0.1 mg%, was identical in the two populations. Compared to a second age- and sex-matched normotensive population, the hypertensives demonstrated a significant (p less than 0.005) relative hypercalciuria. For any level of urinary sodium, hypertensives excreted more calcium. These preliminary data suggest that parathyroid gland function may be enhanced in
essential hypertension
. This increased gland activity appears, in part, to be an appropriate, physiologic response to a previously unrecognized relative hypercalciuria, or renal calcium leak, associated with
essential hypertension
. We conclude that the increased prevalence of hypertension in subjects with hyperparathyroidism probably represents the final event in a continuum that begins with obligatory urinary calcium losses in hypertensives, but whose pathological presentation is hyperparathyroidism. The results of this pilot study indicate a need for derivative experiments directed at defining the importance of our preliminary findings in the pathogenesis of human and experimental hypertension.
...
PMID:Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. 738 May 20
To investigate the possible relationships between blood pressure,
parathyroid hormone
(
PTH
) and platelet cytosolic Ca2+ concentration ([Ca2+]i) in patients with
essential hypertension
, we studied 17 patients with this disease aged 48 +/- 2 years and 17 normotensive controls aged 44 +/- 3 years. Platelet [Ca2+]i was measured by spectrofluorimetry using the dye Fura-2 acetoxymethylester. Patients with
essential hypertension
displayed lower levels of serum ionized Ca2+ (0.99 +/- 0.03 versus 1.1 +/- 0.01 mmol/l, P < 0.05) and higher serum intact
PTH
levels (37 +/- 3 versus 26 +/- pg/ml, (P < 0.01) than the normotensive controls. Although serum levels of intact
PTH
were significantly correlated with mean arterial pressure (MAP) in the combined group of subjects (r = 0.42, P < 0.05), there was no correlation when each group was considered separately. Resting platelet [Ca2+]i was also higher in patients than in controls (57 +/- 3 versus 48 +/- 2 nmol/l, P < 0.005). When platelets were stimulated in vitro with thrombin, the increment in [Ca2+]i was also greater in patients than in controls in the presence of extracellular Ca2+ (264 +/- 24 versus 194 +/- 19 nmol/l, P < 0.05) but not in its absence (123 +/- 12 versus 112 +/- 10 nmol/l). The thrombin-induced increment in [Ca2+]i was correlated with MAP in the hypertensive patients (r = 0.64, P < 0.01) and in the combined group of subjects (r = 0.42, P < 0.05). There was no relationship between resting or thrombin-induced [Ca2+]i and serum
PTH
in either group of patients or in the combined group of subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Parathyroid hormone and platelet cytosolic calcium concentration in essential hypertension. 779 32
The effect of acute volume expansion by saline (1 L/40 min) on serum
parathyroid hormone
(
PTH
) concentration was studied in 28 subjects with mild
essential hypertension
. At the zenith volume expansion there was a significant increase in systolic pressure (7 +/- 2 mm Hg, P < .01) while diastolic pressure and heart rate showed minor (NS) variations. The rise in systolic pressure was accompanied by a significant (P = .02) decrease in plasma ionized calcium (from 1.12 +/- 0.03 to 1.08 +/- 0.03 mmol/L) and by a marked
PTH
increase (from 36 +/- 3 to 60 +/- 4 pg/mL, P < .01). The arterial pressure variations were independent of changes in serum
PTH
. In a second experiment (n = 11), aimed at preventing the changes in calcium concentration brought about by hemodilution, we infused the same volume of saline with the addition of 1.25 mmol of elemental calcium. In this study
PTH
showed a small, nonsignificant, decrease while systolic pressure changes were similar to those of the first study (ie, an isolated 9 +/- 4 mm Hg increase in systolic pressure). In a third experiment (n = 7), aimed at studying the effect of raised plasma
PTH
concentration in isocalcemic conditions, PTH1-38 was continuously infused (1 ng/kg/min) during the volume expansion phase performed with the same solution as used in the second experiment. The hemodynamic changes were again identical to those of the other studies (an isolated 9 +/- 3 mm Hg increase in systolic pressure).(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Influence of extracellular volume expansion on circulating PTH1-84 in subjects with mild essential hypertension. 784 22
Alteration of calcium metabolism and changes in the levels of calcium-regulating hormones have been described in
essential hypertension
. In the majority of the reported clinical trials, calcium supplementation has resulted in a decrease in blood pressure. However, the mechanisms by which such a response would be mediated are entirely unknown. The present study confirmed that daily supplementation with 1.4 g of elemental calcium led to a significant decrease in both systolic and diastolic blood pressures (P < .01). Decrease in blood pressure was negatively correlated with increase in plasma calcitonin gene-related peptide (CGRP), measured with radioimmunoassay and by radioreceptor assay (P < .001), and positively correlated with decrease in intact
parathyroid hormone
(PHT) (P < .05). Following cessation of calcium supplementation, plasma CGRP levels and the blood pressure both reverted back to the base-line values, suggesting a direct effect of supplemented calcium on these two parameters.
...
PMID:Antihypertensive effects of oral calcium supplementation may be mediated through the potent vasodilator CGRP. 813
Elevated levels of serum
parathyroid hormone
(
PTH
) and platelet cytosolic free calcium ([Ca2+]i) have been reported in subjects with
essential hypertension
. In addition, there is a positive correlation between serum
PTH
and platelet [Ca2+]i in white subjects with
essential hypertension
. Black normotensive subjects have relatively higher levels of serum
PTH
when compared to white normotensive subjects. To investigate the possibility that elevated serum
PTH
levels in black normotensives may contribute to elevated platelet [Ca2+]i, calcitropic hormone profiles and platelet [Ca2+]i were determined in 31 black normotensive subjects and 34 age-matched white normotensive subjects. There was no difference between the two groups in total serum calcium, plasma ionized calcium, or creatinine clearance. However, serum
PTH
was significantly elevated (P < .02) in the black normotensive group. Serum 1,25(OH)2 vitamin D levels were similar between the two groups whereas serum 25(OH) vitamin D levels were significantly lower (P < .001) in the blacks. The 24 h urinary excretion of Ca was also lower (P < .05) in the black normotensive group. Basal platelet [Ca2+]i was significantly lower (P < .05) in black normotensive than in white normotensive subjects. Serum
PTH
levels did not correlate with platelet [Ca2+]i in either group, or in the groups combined. These results demonstrate that the higher serum
PTH
concentrations in black normotensives is not associated with higher platelet [Ca2+]i, as is the case in white hypertensive patients.
...
PMID:Racial differences in platelet cytosolic calcium and calcitropic hormones in normotensive subjects. 842 61
<< Previous
1
2
3
4
5
6
7
8
Next >>